News Conference News ACC 2015 Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients Todd Neale March 14, 2015
News Conference News ACC 2014 CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit April 02, 2014
News Conference News ACC 2014 ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients Caitlin E. Cox April 02, 2014
News Conference News ACC 2014 ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates Yael L. Maxwell March 31, 2014
News Conference News ACC 2014 Perioperative Aspirin Increases Major Bleeding After Noncardiac Surgery L.A. McKeown March 31, 2014
News Conference News ACC 2014 HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues Jason Kahn March 31, 2014
Presentation ACC 2014 Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial Presenter: Philippe Généreux March 30, 2014
News Conference News ACC 2014 EUROMAX: Bivalirudin May Hold Key to Solving Problem of Early ST After Primary PCI Jason Kahn March 29, 2014
News Conference News ACC 2013 Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months Jason Kahn March 11, 2013
News Conference News ACC 2013 STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital Yael L. Maxwell March 09, 2013
News Conference News ACC 2013 Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients L.A. McKeown March 09, 2013
News Conference News ACC 2013 Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients Yael L. Maxwell March 09, 2013
Presentation ACC 2013 Strategies of Clopidogrel Load and Atorvastatin Reload to Prevent Ischemic Cerebral Events in Patients Undergoing Protected Carotid Stenting: Results from the Randomized ARMYDA-9 CAROTID Study Presenter: Giuseppe Patti March 08, 2013
News Conference News ACC 2012 Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism L.A. McKeown March 26, 2012
News Conference News ACC 2012 INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI Jason Kahn March 25, 2012
News Conference News ACC 2012 EXOME: New Genetic Sequencing Zeroes in on Clopidogrel Response Variants March 25, 2012
Presentation ACC 2012 A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial Presenter: Myeong-Ki Hong March 25, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012
Presentation ACC 2012 RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel Presenter: Gennaro Sardella March 24, 2012
News Conference News ACC 2012 Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel Jason Kahn March 24, 2012